The Guilfordian

Syringe and Vaccine by NIAID is licensed under CC BY 2.0

Pfizer’s vaccine trial for children under 12 has promising results

Maria Guerrero, Staff Writer October 1, 2021

Pfizer and BioNtech came out with ​​promising results on their Phase 2/3 study for the vaccine for children between ages 5 and 11.  According to a press release on Sept. 20, the trial showed “robust...

The FDA approved Pfizer vaccine, and what it means for Guilford College

Kevin Ma, Guest Writer September 10, 2021

On Aug. 23, the Food and Drug Administration finally approved the Pfizer-BioNTech COVID-19 vaccine, eight months after the vaccine became available to the public under emergency use authorization, paving...

Load More Stories